NZ751589A - Compositions and methods of using islet neogenesis peptides and analogs thereof - Google Patents
Compositions and methods of using islet neogenesis peptides and analogs thereofInfo
- Publication number
- NZ751589A NZ751589A NZ751589A NZ75158914A NZ751589A NZ 751589 A NZ751589 A NZ 751589A NZ 751589 A NZ751589 A NZ 751589A NZ 75158914 A NZ75158914 A NZ 75158914A NZ 751589 A NZ751589 A NZ 751589A
- Authority
- NZ
- New Zealand
- Prior art keywords
- analogs
- peptides
- methods
- compositions
- islet neogenesis
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 230000009707 neogenesis Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000001737 promoting effect Effects 0.000 abstract 2
- 230000008929 regeneration Effects 0.000 abstract 2
- 238000011069 regeneration method Methods 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 101100189458 Mesocricetus auratus INGAP gene Proteins 0.000 abstract 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 208000016097 disease of metabolism Diseases 0.000 abstract 1
- 230000001771 impaired effect Effects 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- 210000005036 nerve Anatomy 0.000 abstract 1
- 230000004112 neuroprotection Effects 0.000 abstract 1
- 230000004203 pancreatic function Effects 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2013/072771 WO2014139182A1 (en) | 2013-03-15 | 2013-03-15 | Compositions and methods of using islet neogenesis peptides and analogs thereof |
NZ711958A NZ711958A (en) | 2013-03-15 | 2014-03-14 | Compositions and methods of using islet neogenesis peptides and analogs thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ751589A true NZ751589A (en) | 2020-08-28 |
Family
ID=72265404
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ751589A NZ751589A (en) | 2013-03-15 | 2014-03-14 | Compositions and methods of using islet neogenesis peptides and analogs thereof |
NZ751591A NZ751591A (en) | 2013-03-15 | 2014-03-14 | Compositions and methods of using islet neogenesis peptides and analogs thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ751591A NZ751591A (en) | 2013-03-15 | 2014-03-14 | Compositions and methods of using islet neogenesis peptides and analogs thereof |
Country Status (1)
Country | Link |
---|---|
NZ (2) | NZ751589A (en) |
-
2014
- 2014-03-14 NZ NZ751589A patent/NZ751589A/en unknown
- 2014-03-14 NZ NZ751591A patent/NZ751591A/en unknown
Also Published As
Publication number | Publication date |
---|---|
NZ751591A (en) | 2020-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019009886A (en) | Compositions and methods of using islet neogenesis peptides and analogs thereof. | |
PH12020550450A1 (en) | Certain chemical entities, compositions and methods | |
PH12018500016A1 (en) | Agents, uses and methods for the treatment of synucleinopathy | |
PH12018500086A1 (en) | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | |
SG10201809457YA (en) | Insulin receptor partial agonists | |
GEP20207147B (en) | Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors | |
SG10201906304TA (en) | Use of perfusion decellularized liver for islet cell recellularization | |
SG10201902872YA (en) | Ex vivo proliferation of epithelial cells | |
MX2019005594A (en) | Agents, uses and methods for the treatment of synucleinopathy. | |
NZ631701A (en) | Apoptosis-including agents for the treatment of cancer and immune and autoimmune diseases | |
PH12019502646A1 (en) | Pyrazole magl inhibitors | |
EA033345B1 (en) | TRICYCLIC SULFONES AS RORĪ³ MODULATORS | |
GB2496337A (en) | Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases | |
MX2018005399A (en) | New polypeptide having affinity to pd-l1. | |
MX2022015248A (en) | Methods of treating inflammatory diseases. | |
MX2013000958A (en) | Manufacture of inter -alpha - inhibitor proteins (iaip) from plasma. | |
BR112017014361A2 (en) | methods for perfecting cell therapy | |
MX2017014456A (en) | Therapeutic uses of l-4-chlorokynurenine. | |
MX367858B (en) | Conotoxin peptides, pharmaceutical compositions and uses thereof. | |
MX2016002931A (en) | Liver x receptor (lxr) modulators. | |
PH12019501683A1 (en) | Rorgamma modulators and uses thereof | |
PH12019501682A1 (en) | Rorgamma modulators and uses thereof | |
EP3810174A4 (en) | Compositions and methods for propagating insulin-producing islet cells and therapeutic uses thereof | |
NZ751591A (en) | Compositions and methods of using islet neogenesis peptides and analogs thereof | |
MX2017003949A (en) | Novel peptide derivatives and uses thereof. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 MAR 2022 BY HENRY HUGHES IP LIMITED Effective date: 20210216 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 MAR 2023 BY HENRY HUGHES IP LIMITED Effective date: 20220208 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 MAR 2024 BY HENRY HUGHES IP LIMITED Effective date: 20230131 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 MAR 2025 BY DENNEMEYER + CO. S.A.R.L. Effective date: 20240304 |